Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Karhoff
01.12.21 -- 6 Things We Need From FDA Before Full 2023 DSCSA Enforcement
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC This article suggests concrete actions the FDA can take to help unify a complex and diverse group of stakeholders prior to enforcing the full requirements of the Drug Supply Chain Security Act (DSCSA) in November 2023.
6 Things We Need From FDA Before Full 2023 DSCSA Enforcement
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC The journey to industry compliance with the U.S. Drug Supply Chain Security Act (DSCSA) continues to twist and turn with recent requirements going into effect for distributors and dispenser and subsequent delays on enforcement of some of those requirements until Nov. 27, 2023.
6 Things We Need From FDA Before Full 2023 DSCSA Enforcement
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC The journey to industry compliance with the U.S. Drug Supply Chain Security Act (DSCSA) continues to twist and turn with recent requirements going into effect for distributors and dispenser and subsequent delays on enforcement of some of those requirements until Nov. 27, 2023.
6 Things We Need From FDA Before Full 2023 DSCSA Enforcement
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC The journey to industry compliance with the U.S. Drug Supply Chain Security Act (DSCSA) continues to twist and turn with recent requirements going into effect for distributors and dispenser and subsequent delays on enforcement of some of those requirements until Nov. 27, 2023.
04.21.20 -- Implementing Data Quality By Design For Improved Data Integrity
Article | By Kevin Lawler, Pelican BioThermal As we cross the threshold into a new decade in 2020, it’s a time to take stock of the significant changes that transformed the pharmaceutical cold chain industry during the past decade. Article | By Anil Kane, Ph.D., MBA, Thermo Fisher Scientific Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.
Helping Pharma Manufacturers Overcome DSCSA Interoperability Pain Points
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC With the FDA guidance documents and requirements of the DSCSA (Drug Supply Chain Security Act) still unfolding, there is a growing need for sectors in the supply chain to align on how to meet various aspects of the law. We believe 2020 and 2021 will be critical years in determining if the industry can align on how to build an interoperable system that meets the basic requirements that should be implemented in 2022 and 2023.
Helping Pharma Manufacturers Overcome DSCSA Interoperability Pain Points
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC With the FDA guidance documents and requirements of the DSCSA (Drug Supply Chain Security Act) still unfolding, there is a growing need for sectors in the supply chain to align on how to meet various aspects of the law. We believe 2020 and 2021 will be critical years in determining if the industry can align on how to build an interoperable system that meets the basic requirements that should be implemented in 2022 and 2023.
04.06.20 -- Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits
Newsletter | April 6, 2020 04.06.20 -- Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits Pharmacokinetic Strategies In CNS Drug Discovery The discovery and clinical development of drugs for many central nervous system (CNS) disorders have remained elusive despite the dramatic increase in our understanding of the central nervous system over the last two decades.
03.26.20 -- Are You Ready For A DSCSA Audit? 5 Steps To Ensure The Answer Is "Yes"
Newsletter | March 26, 2020 Featured Editorial Are You Ready For A DSCSA Audit? 5 Steps To Ensure The Answer Is “Yes” By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC Imagine the FDA showing up at your headquarters or distribution center for an audit. Your team is ready for the gauntlet of questions and is prepared to show proof through procedures, data, and action.
Are You Ready For A DSCSA Audit 5 Steps To Ensure The Answer Is “Yes”
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC Imagine the FDA showing up at your headquarters or distribution center for an audit. Your team is ready for the gauntlet of questions and is prepared to show proof through procedures, data, and action. The team just needs to stay focused and finish the audit and the officials will be on their way.
Are You Ready For A DSCSA Audit 5 Steps To Ensure The Answer Is “Yes”
By Mike Karhoff and Mark Karhoff, Ten Count Consulting, LLC Imagine the FDA showing up at your headquarters or distribution center for an audit. Your team is ready for the gauntlet of questions and is prepared to show proof through procedures, data, and action. The team just needs to stay focused and finish the audit and the officials will be on their way.
5 Barriers To Blockchain Adoption In The Rx Supply Chain - And How To Overcome Them
By Mark Karhoff, Ten Count Consulting, LLC Most stakeholders in the pharma supply chain are aware of the hype and some of the unfolding reality surrounding blockchain. One of the Drug Supply Chain Security Act’s (DSCSA's) more advanced requirements is interoperability, targeted for 2023, which many informed stakeholders believe blockchain can address.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack